Chronic fentanyl treatments induce the up-regulation of μ opioid receptor mRNA in rat pheochromocytoma cells

被引:19
作者
Yoshikawa, M
Nakayama, H
Ueno, S
Hirano, M
Hatanaka, H
Furuya, H
机构
[1] Nara Med Univ, Dept Anesthesiol, Nara 6348522, Japan
[2] Nara Med Univ, Dept Med Genet, Nara, Japan
[3] Nara Med Univ, Dept Pharmacol, Nara, Japan
[4] Osaka Univ, Inst Prot Res, Div Prot Biosynth, Osaka, Japan
关键词
mitogen-activated protein kinase; receptor internalization; RT-PCR;
D O I
10.1016/S0006-8993(00)01961-2
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Chronic activation of adenylate cyclase-cAMP-cAMP-dependent protein kinase (PKA) systems by administration of opioid receptor agonists has been considered as one of the mechanisms of opioid tolerance and dependence. Although analysis of the CL opioid receptor (MOR) gene suggests that cAMP-related signal transduction systems regulate the expression of this gene, which transcription factors affect the MOR gene expression in brain and neural cells has not been clarified. This study deals with the effects of fentanyl on MOR mRNA levels in the rat pheochromocytoma cell line (PC12 cells). PC12 cells were cultured in medium with clinically relevant concentrations of fentanyl. The quantitative reverse transcription and polymerase chain reaction (RT-PCR) method was used for determination of MOR mRNA. Treatment of PC12 cells with fentanyl induced the MOR mRNA up-regulation in a concentration- and time-dependent manner. A cAMP analogue also up-regulated MOR mRNA. The intracellular cAMP level increased after fentanyl treatment. A PKA inhibitor blocked the MOR mRNA up-regulation by fentanyl and the cAMP analogue. Expression of a dominant inhibitory Ras also inhibited the MOR mRNA up-regulation. Fentanyl-induced up-regulation of MOR mRNA via activation of cAMP signaling may be important in compensating for the MOR reduction during long-term treatment of PC12 cells with fentanyl. The present st;dy could be relevant to understanding the molecular mechanisms of opioids in a state of drug tolerance or dependence, and in patients under anesthesia or being treated for pain. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:217 / 223
页数:7
相关论文
共 34 条
[1]  
ABOOD ME, 1995, J PHARMACOL EXP THER, V274, P1566
[2]  
ARDEN JR, 1995, J NEUROCHEM, V65, P1636
[3]   Chronic opioid treatment induces adenylyl cyclase V superactivation - Involvement of G beta gamma [J].
AvidorReiss, T ;
Nevo, I ;
Levy, R ;
Pfeuffer, T ;
Vogel, Z .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (35) :21309-21315
[4]   DIVERSITY IN FUNCTION AND REGULATION OF MAP KINASE PATHWAYS [J].
BLUMER, KJ ;
JOHNSON, GL .
TRENDS IN BIOCHEMICAL SCIENCES, 1994, 19 (06) :236-240
[5]  
Bot G, 1998, J PHARMACOL EXP THER, V285, P1207
[6]   REGULATION OF RAS-MEDIATED SIGNALING - MORE THAN ONE-WAY TO SKIN A CAT [J].
BURGERING, BMT ;
BOS, JL .
TRENDS IN BIOCHEMICAL SCIENCES, 1995, 20 (01) :18-22
[7]  
CHEN Y, 1993, MOL PHARMACOL, V44, P8
[8]   OPIOID RECEPTOR-COUPLED 2ND MESSENGER SYSTEMS [J].
CHILDERS, SR .
LIFE SCIENCES, 1991, 48 (21) :1991-2003
[9]  
ERHARDT P, 1995, MOL CELL BIOL, V15, P5524
[10]   CREB: A major mediator of neuronal neurotrophin responses [J].
Finkbeiner, S ;
Tavazoie, SF ;
Maloratsky, A ;
Jacobs, KM ;
Harris, KM ;
Greenberg, ME .
NEURON, 1997, 19 (05) :1031-1047